相似文献
1
Vitamin B12 and hepatitis C: molecular biology and human pathology.
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4916-21. doi: 10.1073/pnas.081072798. Epub 2001 Apr 10.
2
Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein.
J Virol. 2004 Nov;78(21):12075-81. doi: 10.1128/JVI.78.21.12075-12081.2004.
3
Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Liver Int. 2005 Jun;25(3):580-94. doi: 10.1111/j.1478-3231.2005.01082.x.
4
Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site.
J Mol Biol. 2002 May 24;319(1):1-8. doi: 10.1016/S0022-2836(02)00300-5.
5
Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
J Infect Dis. 2002 Jul 15;186(2):155-63. doi: 10.1086/341467. Epub 2002 Jul 3.
6
Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Mol Cell Biol. 2001 Dec;21(24):8357-64. doi: 10.1128/MCB.21.24.8357-8364.2001.
7
Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Antiviral Res. 2008 Dec;80(3):280-7. doi: 10.1016/j.antiviral.2008.06.011. Epub 2008 Jul 14.
8
The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
Biochem Soc Trans. 2002 Apr;30(2):140-5.
9
A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
J Virol. 2005 Aug;79(15):9842-53. doi: 10.1128/JVI.79.15.9842-9853.2005.
10
Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Antivir Ther. 2004 Dec;9(6):953-68.
引用本文的文献
1
Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease.
J Clin Med. 2022 Jul 13;11(14):4049. doi: 10.3390/jcm11144049.
2
Medicinal Animals and Plants as Alternative and Complementary Medicine in Southern Regions of Khyber Pakhtunkhwa, Pakistan.
Front Pharmacol. 2021 Aug 20;12:649046. doi: 10.3389/fphar.2021.649046. eCollection 2021.
3
The Presence of Circulating Nucleated Red Blood Cells Is Associated With Disease Severity in Patients of Hemorrhagic Fever With Renal Syndrome.
Front Med (Lausanne). 2021 May 25;8:665410. doi: 10.3389/fmed.2021.665410. eCollection 2021.
4
COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice?
Med Hypotheses. 2021 Jan;146:110374. doi: 10.1016/j.mehy.2020.110374. Epub 2020 Nov 12.
5
New opportunities for designing effective small interfering RNAs.
Sci Rep. 2019 Nov 6;9(1):16146. doi: 10.1038/s41598-019-52303-5.
6
The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus.
Cells. 2019 Jun 17;8(6):603. doi: 10.3390/cells8060603.
7
Association of serum vitamin B12 levels with stage of liver fibrosis and treatment outcome in patients with chronic hepatitis C virus genotype 1 infection: a retrospective study.
BMC Res Notes. 2015 Jun 25;8:260. doi: 10.1186/s13104-015-1248-z.
8
Individualized therapy for hepatitis C infection: focus on the interleukin-28B polymorphism in directing therapy.
Mol Diagn Ther. 2014 Feb;18(1):25-38. doi: 10.1007/s40291-013-0053-4.
9
HCV IRES-mediated core expression in zebrafish.
PLoS One. 2013;8(3):e56985. doi: 10.1371/journal.pone.0056985. Epub 2013 Mar 1.
10
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.
World J Gastroenterol. 2011 Dec 21;17(47):5184-90. doi: 10.3748/wjg.v17.i47.5184.
本文引用的文献
1
Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on PolyA(+)-purified RNA.
Hepatology. 2000 Aug;32(2):382-7. doi: 10.1053/jhep.2000.9094.
2
Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8566-71. doi: 10.1073/pnas.97.15.8566.
3
The structural basis for molecular recognition by the vitamin B 12 RNA aptamer.
Nat Struct Biol. 2000 Jan;7(1):53-7. doi: 10.1038/71253.
4
Translation of hepatitis C virus RNA.
J Viral Hepat. 1999 Mar;6(2):79-87. doi: 10.1046/j.1365-2893.1999.00150.x.
5
Internal ribosome entry site-mediated translation in hepatitis C virus replication.
Curr Top Microbiol Immunol. 2000;242:85-116. doi: 10.1007/978-3-642-59605-6_5.
6
Translating ribosomes inhibit poliovirus negative-strand RNA synthesis.
J Virol. 1999 Dec;73(12):10104-12. doi: 10.1128/JVI.73.12.10104-10112.1999.
7
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation.
J Virol. 1999 Dec;73(12):9718-25. doi: 10.1128/JVI.73.12.9718-9725.1999.
8
RNA-triggered gene silencing.
Trends Genet. 1999 Sep;15(9):358-63. doi: 10.1016/s0168-9525(99)01818-1.
9
Receptor-mediated endocytosis of cobalamin (vitamin B12).
Annu Rev Nutr. 1999;19:173-95. doi: 10.1146/annurev.nutr.19.1.173.
10
A potential mechanism for selective control of cap-independent translation by a viral RNA sequence in cis and in trans.
RNA. 1999 Jun;5(6):728-38. doi: 10.1017/s1355838299981979.
Zotero 插件